---
title: "BIOCAUSE HEILEN PHARMA released its performance for the first three quarters, with a net profit attributable to the parent company of 20.9334 million yuan, a decrease of 71.96%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262852609.md"
description: "BIOCAUSE HEILEN PHARMA released its Q3 2025 report, with operating revenue for the first three quarters amounting to 319 million yuan, a year-on-year decrease of 4.52%. The net profit attributable to the parent company was 20.9334 million yuan, a year-on-year decline of 71.96%; the net profit after deducting non-recurring gains and losses was 543,800 yuan, a year-on-year decrease of 99.14%. The basic earnings per share were 0.05 yuan"
datetime: "2025-10-27T09:15:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262852609.md)
  - [en](https://longbridge.com/en/news/262852609.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262852609.md)
---

# BIOCAUSE HEILEN PHARMA released its performance for the first three quarters, with a net profit attributable to the parent company of 20.9334 million yuan, a decrease of 71.96%

According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA (301211.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 319 million yuan, a year-on-year decrease of 4.52%. The net profit attributable to shareholders of the listed company was 20.9334 million yuan, a year-on-year decrease of 71.96%. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 543,800 yuan, a year-on-year decrease of 99.14%. The basic earnings per share were 0.05 yuan

### Related Stocks

- [301211.CN](https://longbridge.com/en/quote/301211.CN.md)

## Related News & Research

- [Oil edges higher as Iranian attacks on ships in Strait of Hormuz without U.S. response rise](https://longbridge.com/en/news/296280231.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [Aquarius crosses 10% stake in Carvolix, holds 11.65% of shares](https://longbridge.com/en/news/296112439.md)
- [REG - Nomura Intl. PLC Spire Healthcare Grp - Form 8.3 - SPIRE HEALTHCARE GROUP PLC](https://longbridge.com/en/news/296096467.md)
- [Max Power to present Lawson natural hydrogen discovery at IMAGE ’26 in Houston](https://longbridge.com/en/news/296226273.md)